发明名称 METHODS FOR TREATING INFLAMMATORY AUTOIMMUNE DISORDERS
摘要 The present invention features a method of treating or reducing the likelihood of an inflammatory autoimmune disorder (e.g., systemic lupus erythematosus (SLE)) or a kidney disorder (e.g., glomerulonephritis) in a subject by administering an inhibitor of calcium/calmodulin-dependent protein kinase type IV (CaMKIV). The invention additionally features methods of diagnosing a subject with SLE or a kidney disorder by determining the level or biological activity of a CaMKIV nucleic acid or polypeptide in a sample from a subject. Also included in the invention are methods for identifying compounds that inhibit CaMKIV for the treatment of an inflammatory autoimmune disorder (e.g., SLE) or a kidney disorder (e.g., glomerulonephritis).
申请公布号 US2014161769(A1) 申请公布日期 2014.06.12
申请号 US201313936792 申请日期 2013.07.08
申请人 Beth Israel Deaconess Medical Center, Inc. 发明人 Tsokos George C.;Juang Yuang-Taung;Hahn Chun-Shin
分类号 A61K31/18;A61K31/713;A61K45/06;C12N15/113 主分类号 A61K31/18
代理机构 代理人
主权项 1. A method of treating or reducing the likelihood of an inflammatory autoimmune disorder or a kidney disorder in a subject, said method comprising providing to said subject an inhibitor of calcium/calmodulin-dependent protein kinase type IV (CaMKIV), wherein said inhibitor is provided in an amount and for a duration that together are sufficient to treat or reduce the likelihood of said inflammatory autoimmune disorder or said kidney disorder in said subject.
地址 Boston MA US